SCHEMBL8949294

SCHEMBL8949294

N#Cc1ccc(-c2cc(C(=O)O)c(=O)n(Cc3ccccc3)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.46
CNR2 P34972 3/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
TDP1 Q9NUW8 1/20 0.44
POLB P06746 1/20 0.44
SLC2A1 P11166 1/20 0.43
SLC2A3 P11169 1/20 0.43
SLC2A4 P14672 1/20 0.43
MAPT P10636 2/20 0.43
GALR3 O60755 1/20 0.43
GAA P10253 1/20 0.43
NPY1R P25929 1/20 0.43
STAT3 P40763 1/20 0.43
NPY2R P49146 1/20 0.43
CASP1 P29466 1/20 0.42
AR P10275 1/20 0.42
CYP19A1 P11511 1/20 0.42
CHRM4 P08173 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8949195 0.86 SMN1; SMN2 (0.59) MEN1KMT2ASMN1; SMN2TDP1POLB
Benzyl Bromide SCHEMBL9263877 0.82 SMN1; SMN2 (0.54) MEN1KMT2ASMN1; SMN2TDP1POLB
SCHEMBL7723670 0.81 MAPT (0.63) MEN1KMT2ASMN1; SMN2TDP1POLB
SCHEMBL8949362 0.81 CNR2 (0.61) CNR1CNR2SMN1; SMN2CHRM4
SCHEMBL8949327 0.78 CNR2 (0.60) CNR1CNR2MEN1KMT2ACHRM4
SCHEMBL7275259 0.78 PHGDH (0.48) MEN1KMT2AGAACASP1
SCHEMBL1925446 0.77 CNR2 (0.49) CNR1CNR2MEN1KMT2ASMN1; SMN2
SCHEMBL27538726 0.76 CNR2 (0.46) CNR1CNR2MEN1KMT2ASMN1; SMN2
SCHEMBL8949200 0.76 TSHR (0.46) MEN1KMT2ASMN1; SMN2POLBGAA
SCHEMBL7724840 0.73 MAPT (0.61) KMT2ASMN1; SMN2TDP1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5563268-A FOR PREVENTING CELL AGGLOMERATION, TREATING THROMBOSIS, ARTERIOSCLEROSIS, BRAIN, LUNG OR CARDIOVASCULAR DISORDERS DR. KARL THOMAE GMBH (DE) 1996-10-08 US disclosed
US-5418233-A FOR INHIBITING CELL AGGREGATION KARL THOMAE GMBH (DE) 1995-05-23 US disclosed
EP-0537696-A1 Heterobiaryl derivatives, medicines containing those compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1993-04-21 EP disclosed